Telos Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
46,049
-417
-0.9% -$97.2K 1.03% 32
2026
Q1
$11.4M Sell
46,466
-1,468
-3% -$342K 1.09% 29
2025
Q4
$9.92M Sell
47,934
-1,195
-2% -$236K 0.92% 34
2025
Q3
$9.11M Buy
49,129
+203
+0.4% +$34.8K 0.87% 36
2025
Q2
$7.47M Buy
48,926
+467
+1% +$71.8K 0.76% 47
2025
Q1
$8.04M Sell
48,459
-5,837
-11% -$913K 0.88% 33
2024
Q4
$7.85M Buy
54,296
+705
+1% +$109K 0.84% 35
2024
Q3
$8.69M Sell
53,591
-1,721
-3% -$274K 0.91% 35
2024
Q2
$8.08M Sell
55,312
-14,227
-20% -$2.12M 0.9% 35
2024
Q1
$11M Sell
69,539
-3,783
-5% -$602K 1.24% 26
2023
Q4
$11.5M Sell
73,322
-2,103
-3% -$322K 1.4% 20
2023
Q3
$11.7M Buy
75,425
+252
+0.3% +$41.6K 1.63% 15
2023
Q2
$12.4M Sell
75,173
-103
-0.1% -$16.6K 1.66% 14
2023
Q1
$11.7M Buy
75,276
+104
+0.1% +$16.8K 1.63% 13
2022
Q4
$13.3M Sell
75,172
-694
-0.9% -$120K 1.93% 8
2022
Q3
$12.4M Buy
75,866
+4,048
+6% +$685K 2.04% 7
2022
Q2
$12.7M Sell
71,818
-468
-0.6% -$83.4K 1.95% 7
2022
Q1
$12.8M Sell
72,286
-2,815
-4% -$479K 1.66% 11
2021
Q4
$12.8M Buy
75,101
+2,040
+3% +$334K 1.61% 14
2021
Q3
$11.8M Sell
73,061
-987
-1% -$168K 1.62% 14
2021
Q2
$12.2M Buy
74,048
+2,070
+3% +$343K 1.61% 11
2021
Q1
$11.8M Sell
71,978
-1,908
-3% -$309K 1.7% 10
2020
Q4
$11.6M Sell
73,886
-55
-0.1% -$8.12K 1.77% 9
2020
Q3
$11M Buy
73,941
+4,782
+7% +$708K 1.92% 9
2020
Q2
$9.73M Buy
69,159
+1,024
+2% +$149K 1.88% 10
2020
Q1
$8.94M Buy
68,135
+26,626
+64% +$3.78M 2.21% 6
2019
Q4
$6.05M Buy
41,509
+9,888
+31% +$1.34M 1.38% 14
2019
Q3
$4.09M Buy
31,621
+3,320
+12% +$437K 1.12% 28
2019
Q2
$3.94M Buy
28,301
+724
+3% +$100K 1.16% 27
2019
Q1
$3.85M Buy
27,577
+1,961
+8% +$263K 1.2% 25
2018
Q4
$3.31M Buy
25,616
+547
+2% +$76.3K 1.22% 25
2018
Q3
$3.46M Buy
25,069
+33
+0.1% +$4.38K 1.11% 26
2018
Q2
$3.04M Buy
25,036
+1,495
+6% +$187K 1.05% 31
2018
Q1
$3.02M Sell
23,541
-281
-1% -$38K 1.07% 31
2017
Q4
$3.33M Buy
23,822
+535
+2% +$74.5K 1.17% 23
2017
Q3
$3.03M Sell
23,287
-4,116
-15% -$546K 1.17% 24
2017
Q2
$3.63M Sell
27,403
-34
-0.1% -$4.34K 1.45% 15
2017
Q1
$3.42M Sell
27,437
-2,260
-8% -$270K 1.42% 15
2016
Q4
$3.42M Buy
29,697
+633
+2% +$73.1K 1.52% 14
2016
Q3
$3.43M Buy
29,064
+114
+0.4% +$13.8K 1.6% 13
2016
Q2
$3.51M Sell
28,950
-1,161
-4% -$132K 1.72% 8
2016
Q1
$3.26M Buy
30,111
+2,224
+8% +$230K 1.71% 9
2015
Q4
$2.86M Buy
27,887
+1,059
+4% +$106K 1.54% 12
2015
Q3
$2.5M Buy
26,828
+1,946
+8% +$188K 1.53% 13
2015
Q2
$2.42M Buy
24,882
+3,011
+14% +$302K 1.34% 17
2015
Q1
$2.2M Buy
21,871
+1,701
+8% +$173K 1.28% 17
2014
Q4
$2.11M Buy
20,170
+769
+4% +$81K 1.29% 18
2014
Q3
$2.07M Buy
19,401
+769
+4% +$79.8K 1.29% 15
2014
Q2
$1.95M Buy
18,632
+46
+0.2% +$4.65K 1.21% 17
2014
Q1
$1.83M Buy
18,586
+774
+4% +$71.8K 1.28% 18
2013
Q4
$1.63M Sell
17,812
-6,665
-27% -$614K 1.2% 20
2013
Q3
$2.12M Buy
24,477
+513
+2% +$46K 1.72% 11
2013
Q2
$2.06M Buy
+23,964
New +$2.03M 1.81% 11

Other funds holding JNJ

Telos Capital Management's JNJ Position: Q2 2026 in Review

Telos Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.9% in Q2 2026, selling an estimated $97.2K and leaving 46,049 shares worth $11.7M. The position accounts for 1.03% of the portfolio, ranked #32.

Telos Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q4 2022. 1,713 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Telos Capital Management held 46,049 shares of Johnson & Johnson worth $11.7M as of Q2 2026.
  • Telos Capital Management sold 417 Johnson & Johnson shares in Q2 2026, an estimated $97.2K.
  • Johnson & Johnson made up 1.03% of Telos Capital Management's portfolio in Q2 2026, its #32 holding.
  • Telos Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Telos Capital Management's Johnson & Johnson position peaked at $13.3M in Q4 2022.
  • 1,713 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.